A recent study published in the journal Scientific Reports evaluated the durability of neutralizing antibody (nAb) responses induced after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...

Guillain–Barré syndrome (GBS) after COVID-19 vaccination is more common among individuals receiving adenovirus-vectored vaccines compared with mRNA vaccines. Investigators conducted a systematic ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

The mRNA vaccines we are currently using are not sufficient to stop the ongoing Covid-19 pandemic. Although they have been critical in the fight against SARS-CoV-2, they suffer from a glaring ...

Even before the World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020, the scientific community was mobilizing to develop vaccines with the hope of protecting us all.

In a recent study published in Nature Immunology, a team of researchers from the United States used non-human primate models to compare the protection conferred by an intramuscular booster dose of the ...